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MICROARRAY LEUKEMIADATA
DENISE J. HARNESS | HARNESSD@ETSU.EDU | EAST TENNESSEE STATE UNIVERSITY HONORS COLLEGE
MICROARRY DATA
A DNA microarray measures the simultaneous
expression of tens of thousands of genes in a pa-
tient. Rows are observations and columns are in-
dividual genes. The Leukemia data contains 72
observations and 7,129 genes. A subset of this
data is shown below. Microarray data can be dif-
ficult to apply machine learning to because it typ-
ically has very few observations and many fea-
tures.
MULTIVARIATE GAUSSIAN
The factors in a structured data set are often con-
sidered to be random variables jointly distributed
as a multivariate Gaussian, as shown in Eq. 1:
f(X1, X2, ..., Xk) ∼ 1√
(2pi)k|C|e
(k−µ)TC−1(k−µ)
2
(1)
Where x is the vector of X1...Xn. In practice,
we assume a multivariate Gaussian distribution
if empirical residuals are jointly Gaussian.
We view the resid-
uals of the features
and assume a Gaus-
sian prior is present in
the leukemia data.
COVARIANCE MATRIX
The covariance of two random variables is the
expected product of their deviations from their
means. Covariance is reported in the product of
the units of the variables. C = 1k−1X
TX defines
the empirical covariance matrix as a function of
the leukemia data, X .
PRECISION MATRIX
The inverse of the theoretical covariance matrix is
simply the precision matrix, P , as shown in Eq. 2:
P = C−1 (2)
The precision matrix is a way of showing asso-
ciations or relationships among factors. This can
be turned into a probabilistic graphical model,
where each node in the graph is a gene with a
probability associated to it. We need to avoid
inverting the empirical covariance matrix unless
it is both small and well-conditioned, which the
Leukemia data is not.
PARTIAL CORRELATION
It has been shown for the case of a Gaussian
model there is an exact correspondence between
the location of the non - zero entries in the pre-
cision matrix and the existence of partial correla-
tions between the random variables. Partial cor-
relations model the association between two fea-
tures while adjusting for the effect of one or more
additional features, as shown in Eq. 3:
ρi,j =
−ri,j√
ri,irj,j
(3)
Partial correlations are ρ and the coefficients of
the precision matrix are represented by ri,j . Thus
a probabilistic graphical model of the relation-
ships (partial correlations) among features can be
used as a surrogate for the true precision matrix.
GOAL
To compare the probabilistic modeling approach
with traditional feature selection methods.
METHODS
1. Standardize data and remove first column.
2. A Python 3 script was written to loop and create a matrix of partial correlations.
3. Lower triangular part of matrix and diagonal not calculated, because symmetric and all 1’s.
4. Still have over 25 million entries, only top 100 partial correlation values and their corresponding positions in
the matrix were stored.
5. The computation time on a single processor is about 10 days.
6. We ran 10% of the data at a time and saved after each run.
7. A network structure can be inferred using a Probabilistic Graphical Model, shown below in figure.
8. Reduced to 179 genes predicted to be the “more important” features in predicting Leukemia.
RESULTS
The graph of the top 100 partial correlations is
shown below. These are the features which make
up the reduced feature set.
We used Random Forest and Linear Kernel Sup-
port Vector Machine algorithms to access the pre-
diction accuracy of the reduced feature set. The
mean and standard deviation of the accuracy of
100 iterations of the random forest algorithm is
shown in the table.
Full Reduced
Mean 0.918 0.843
Standard Dev. 0.073 0.075
The prediction accuracies and F-Scores of the SVM
algorithm were similar.
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CONCLUSION
• Overall, the partial correlation method was
able to reduce the full leukemia data set by
97%, from 7,129 features to 179 and maintain
good prediction accuracy using both ma-
chine learning algorithms.
• These findings suggest the genes most re-
sponsible for Leukemia are among the 179
identified by the PGM approach.
• Although machine learning is sophisticated,
it should not be performed independently
from the field which the data came from. We
would need to work with a biomedical re-
searcher to confirm these findings.
• By knowing the 3 − 5% most important
genes in leukemia diagnosis, the activation
of fewer genes must be studied, potentially
leading to faster and less expensive results.
• This method can be applied to other data
sets to learn about the underlying network
structure between the features.
FUTURE RESEARCH
Using more than 100 partial correlations could provide additional information about the gene activation
in a patient with leukemia and increase the prediction accuracy. Future research may include consider-
ing other methods of producing more Laplacians matrices.
